138 related articles for article (PubMed ID: 197548)
1. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
[No Abstract] [Full Text] [Related]
2. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
3. Effects of the combination of nicotinic acid and propranolol in very low doses on blood lipids in man.
Avogaro P; Capri C; Cazzolato G; Pais M; Trabuio GF
Atherosclerosis; 1974; 20(2):395-400. PubMed ID: 4369975
[No Abstract] [Full Text] [Related]
4. [Familial hyperlipoproteinemia type III].
Patsch JR; Patsch W; Sailer S; Braunsteiner H
Dtsch Med Wochenschr; 1976 Oct; 101(44):1612-9. PubMed ID: 185039
[No Abstract] [Full Text] [Related]
5. Dietary and drug treatment of hyperlipidaemia. A feasibility study in asymptomatic middle-aged men.
Hedstrand H
Ups J Med Sci; 1976; 81(2):85-92. PubMed ID: 183322
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
Klemens UH; von Löwis P
Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
[No Abstract] [Full Text] [Related]
7. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Orö L; Olsson AG; Rössner S; Carlson LA
Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
[No Abstract] [Full Text] [Related]
8. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
9. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Rider AK
JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
[No Abstract] [Full Text] [Related]
10. Bile acid kinetics and steroid balance during nicotinic acid therapy in patients with hyperlipoproteinemia types II and IV.
Einarsson K; Hellström K; Leijd B
J Lab Clin Med; 1977 Oct; 90(4):613-22. PubMed ID: 198500
[No Abstract] [Full Text] [Related]
11. [The effect of etofibrate on serum cholesterol and triglycerides (author's transl)].
Dimroth H
Med Klin; 1979 Jun; 74(22):875-6. PubMed ID: 470785
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
Millett F; Sielski J; Stoll H; Alston N; Gail S
PA J; 1976; 6(2):54-9. PubMed ID: 10235781
[No Abstract] [Full Text] [Related]
13. Dietary and drug treatment of primary hyperlipoproteinemia.
Ann Intern Med; 1972 Aug; 77(2):267-94. PubMed ID: 4345081
[No Abstract] [Full Text] [Related]
14. Pseudohomozygous type II hyperlipoproteinemia.
Morganroth J; Levy RI; McMahon AE; Gotto AM
J Pediatr; 1974 Nov; 85(5):639-43. PubMed ID: 4370845
[No Abstract] [Full Text] [Related]
15. Clofibrate in type II hyperlipoproteinemia.
Ditzel J; Bang HO
Acta Med Scand; 1976; 200(1-2):55-58. PubMed ID: 183462
[TBL] [Abstract][Full Text] [Related]
16. Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
Levy RI
JAMA; 1973 Nov; 226(6):648-9. PubMed ID: 4356846
[No Abstract] [Full Text] [Related]
17. Hypolipidemic drugs and lipoprotein metabolism.
Levy RI; Langer T
Adv Exp Med Biol; 1972; 26(0):155-63. PubMed ID: 4370081
[No Abstract] [Full Text] [Related]
18. A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
Mann JI; Harding PA; Turner RC; Wilkinson RH
Br J Clin Pharmacol; 1977 Jun; 4(3):305-8. PubMed ID: 197982
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
Haacke H; Parwaresch MR; Mäder C
Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
[TBL] [Abstract][Full Text] [Related]
20. Clinical and metabolic effects of pentaerythritol tetranicotinate(Perycit)and a comparison with plain nicotinic acid.
Olsson AG; Orö L; Rössner S
Atherosclerosis; 1974; 19(1):61-73. PubMed ID: 4359183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
